Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
The summary for the Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention - ERA, which is the U.S. government agency offering this grant.
Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS): CDC/ATSDR is inviting research proposals to study risk factors for Amyotrophic Lateral Sclerosis (ALS). Studies on military service, contact sports, traumatic brain injury, neuroinflammation, and infections agents and exposures are encouraged. Funding will be for four funding options: Option A - Support research with strong existing evidence such as studies on known environmental or genetic risk factors, research that improves past studies with better data, or investigations linking risk factors to ALS diagnosis and treatment; Option B - Support new and exploratory research on ALS risk factors such as studies on risk factors with little existing evidence or research using innovative methods; Option C - Understand ALS risk in affected populations, such as studies involving military veterans or investigations of ALS risk factors impacting this population; Option D - Analyze biological samples from the Guamanian ALS cluster such as investigation of disease mechanisms and environmental factors, exposure routes, genetic studies and biomarkers and how this could lead to mitigation therapeutics, diagnostics or prevention.
| Federal Grant Title: | Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) |
| Federal Agency Name: | Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA) |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-TS-26-165 |
| Type of Funding: | Cooperative Agreement |
| CFDA Numbers: | 93.061 |
| CFDA Descriptions: | Information not provided |
| Current Application Deadline: | June 10th, 2026 |
| Original Application Deadline: | June 10th, 2026 |
| Posted Date: | May 11th, 2026 |
| Creation Date: | May 11th, 2026 |
| Archive Date: | May 12th, 2027 |
| Total Program Funding: | $4,500,000 |
| Maximum Federal Grant Award: | $500,000 |
| Minimum Federal Grant Award: | $0 |
| Expected Number of Awards: | 3 |
| Cost Sharing or Matching: | No |
| Last Updated: | May 11th, 2026 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification.) - Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Additional Information on Eligibility
- Additional Eligibility Information to be included in the NOFO.
- Grant Announcement Contact
- Dr. Candis Hunter
[email protected]
[email protected] - Similar Government Grants
- • PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Re...
- • PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Re...
- • Identify, Analyze, and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (...
- • PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Re...
- • Cdc Public Health Research: Health Protection Research Initiative Graduate Training Progra...
- • Improving Public Health Practice through Translation Research (R18)
- • CDC Health Protection Research Initiative: Evaluation of Workplace Health Promotion Resear...
- More Grants from the Centers for Disease Control and Prevention - ERA
- • US Travelers Health Research, Surveillance, Communication, and Outreach Network
- • Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-asso...
- • Eliminating Parasitic and Neglected Tropical Disease Threats to the United States - Progra...
- • Research Grants for Preventing Interpersonal Violence and Suicide Among Youth and Young Ad...
- • Grants to Support New Investigators in Conducting Research Related to Preventing Interpers...
